4//SEC Filing
Barclay Alec 4
Accession 0000899243-21-007771
CIK 0001492674other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 2:14 PM ET
Size
8.9 KB
Accession
0000899243-21-007771
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Common Stock
2021-02-21+10,000→ 72,527 total - Exercise/Conversion
Restricted Stock Units
2021-02-21−10,000→ 10,000 total→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-02-23$2.06/sh−7,280$14,997→ 65,247 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 16,233 shares acquired under the Issuer's employee stock purchase plan on November 15, 2020.
- [F3]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018.
- [F4]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001734339
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 2:14 PM ET
- Size
- 8.9 KB